Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Gufic Bio
Gufic Bio
BSE: 509079NSE: GUFICBIOISIN: INE742B01025

3rd-Dec-2019 20:41Source: BSE

Gufic Biosciences - Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

This is in reference to our earlier letters dating from 24th October, 2019 to 5th November, 2019, regarding admission of petition by the Hon''ble National Company Law Tribunal (''NCLT''), Mumbai Bench, filed by one of the Operational creditors, M/s. Scorpion Express Private Limited (''Scorpion'') for initiating Corporate Insolvency Resolution Process against the Company and subsequent appointment of Mr. Indrajit Mukherjee as the Interim Resolution Professional (''IRP'') in the matter.

We are pleased to inform you that NCLT vide its order dated 3rd December, 2019 has recalled its orders dated 22nd October, 2019 and 25th October, 2019 in respect of admission of petition filed by Scorpion and appointment of the IRP respectively. Mr. Indrajit Mukherjee has been discharged from his role as the IRP vide the aforesaid order. In view of the aforesaid, the management has now been restored back to the Board of Directors of the Company.

Request you to take the above on record.

More Announcements on:

7th-Nov-2019 20:10Source: BSE

Gufic Biosciences - Closure of Trading Window

1 2 3 4 5 Next >>
Sections
Follow us on
Available On